Antiparasitics discovery: from genotype to phenotype to compounds.

Clicks: 137
ID: 283174
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #10 of 10 articles by views in Trends in parasitology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
For decades, the discovery of antiparasitics was dominated by whole-organism screening of intact parasite organisms or surrogate parasite models, such as Caenorhabitis elegans, using in vivo animal models or in vitro parasite assays, the latter also known as phenotypic screening. Molecular target-based screening played only a minor role, if at all. While publications using phenotypic screening are abundant in the literature, publications of successful, marketed, antiparasitic drugs discovered using the molecular target-based approach are scarce. This approach, therefore, is often perceived as less relevant for antiparasitic drug discovery than the two other approaches. However, antiparasitics belonging, for example, to the isoxazolines, bispyrazoles, depsipeptides or praziquantel (PZQ) derivatives, imposingly demonstrate the value of this approach, when wisely used in a cooperative manner with phenotypic screening.
Reference Key
marhöfer2025antiparasitics Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Marhöfer, Richard J; Noack, Sandra; Selzer, Paul M
Journal Trends in parasitology
Year 2025
DOI
10.1016/j.pt.2025.04.007
URL
Keywords
mode of action phenotypic screening antiparasitics resistance-breaking target-based screening

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.